Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000930413-24-000267
Filing Date
2024-01-22
Accepted
2024-01-22 07:15:46
Documents
1

Document Format Files

Seq Description Document Type Size
1 c107818_sc13g.htm SC 13G 52225
  Complete submission text file 0000930413-24-000267.txt   53814
Mailing Address 641 LEXINGTON AVENUE 26TH FLOOR NEW YORK, NY 10022
Business Address 641 LEXINGTON AVENUE 26TH FLOOR NEW YORK, NY 10022 212.974.3070
Iroquois Capital Management, LLC (Filed by) CIK: 0001481867 (see all company filings)

EIN.: 010786483 | State of Incorp.: DE
Type: SC 13G

Mailing Address 101-1220 WEST 6TH AVENUE VANCOUVER, BRITISH COLUMBIA Z4 V6H1A5
Business Address 101-1220 WEST 6TH AVENUE VANCOUVER, BRITISH COLUMBIA Z4 V6H1A5 972-54-5704749
Clearmind Medicine Inc. (Subject) CIK: 0001892500 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1031
Type: SC 13G | Act: 34 | File No.: 005-93839 | Film No.: 24547078
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)